Julie Wang
Researcher and clinical trial collaborator in MDMA-assisted psychotherapy
Papers
Trials
Key Impact
She is a recurring author on major MDMA-assisted therapy studies, including Phase 2/3 PTSD trials and related neuroimaging and subgroup analyses that have helped establish the clinical evidence base for psychedelic-assisted treatment.
Background & Research
Julie B. Wang appears as an author on multiple MAPS-affiliated studies of MDMA-assisted psychotherapy, including randomized controlled trials, pooled analyses, and follow-up outcomes in PTSD and related indications. Publicly available author listings place her on papers alongside researchers such as Michael Mithoefer, Amy Emerson, Rick Doblin, and Jennifer M. Mitchell, indicating a substantial role in the clinical research program.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →